Synphatec

Synphatec is a company headquartered in China. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences.

Synphatec develops biopharmaceuticals using proprietary small-molecule and intracranial delivery platforms to create targeted therapeutics for psychiatric and neurodegenerative central nervous system disorders, focusing on conditions such as depression and Alzheimer's disease.